CVE-2023-22868

Published: Feb 17, 2023Modified: Jun 17, 2026

5.4

Vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Exploitability: 2.3 / Impact: 2.7

Source: NVD

Description

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Affected (2)

Products: Ibm: Aspera Faspex

1 product

Configuration A

2 vulnerable · 2 platform

Vulnerable Software	Affected Versions
Ibm Aspera Faspex	Up to 4.4.1
Ibm Aspera Faspex	Version 4.4.1 patch_level_1

Running on/with	Platform Versions
Linux Linux Kernel	All versions
Microsoft Windows	All versions

Related CWEs

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

References (4)

https://exchange.xforce.ibmcloud.com/vulnerabilities/244117

Source: psirt@us.ibm.com

VDB EntryVendor Advisory

https://www.ibm.com/support/pages/node/6952319

Source: psirt@us.ibm.com

PatchVendor Advisory

https://exchange.xforce.ibmcloud.com/vulnerabilities/244117

Source: af854a3a-2127-422b-91ae-364da2661108

VDB EntryVendor Advisory

https://www.ibm.com/support/pages/node/6952319

Source: af854a3a-2127-422b-91ae-364da2661108

PatchVendor Advisory

Timeline

No history available yet.